Skip to main content
Clinical Trials/NL-OMON52149
NL-OMON52149
Withdrawn
Not Applicable

A randomized trial of ultrasound-facilitated, catheter-directed, thrombolysis versus anticoagulation for acute intermediate-high risk pulmonary embolism: The higher-risk pulmonary embolism thrombolysis study - S2479 - Hi-PEITHO

Boston Scientific Corporation0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary embolism
Sponsor
Boston Scientific Corporation
Enrollment
45
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 18\-80 years, inclusive
  • 2\) Objectively confirmed acute PE, based on CTPA showing a filling defect in at
  • least one main or proximal lobar pulmonary artery (PA)
  • 3\) Elevated risk of early death/hemodynamic collapse, indicated by at least two
  • of the following new\-onset clinical criteria:
  • i. Electrocardiogram (ECG)\-documented tachycardia with heart rate \*100 beats
  • per minute, not due to hypovolemia, arrhythmia, or sepsis;
  • ii. SBP \* 110 mm Hg for at least 15 minutes;
  • iii. respiratory rate \> 20 x min\-1 or oxygen saturation on pulse oximetry
  • (SpO2\) \< 90% (or partial arterial oxygen pressure \< 60 mmHg) at rest while

Exclusion Criteria

  • 1\) Hemodynamic instability\*, i.e. at least one of the following present:
  • a) cardiac arrest or need for cardiopulmonary resuscitation;
  • b) need for ECMO, or ECMO initiated before randomization
  • c) PE\-related shock, defined as: (i) SBP \< 90 mmHg, or vasopressors required to
  • achieve SBP \* 90 mmHg, despite an adequate volume status; and (ii) end\-organ
  • hypoperfusion (altered mental status; oliguria/anuria; increased serum lactate);
  • d) isolated persistent hypotension (SBP \< 90 mmHg, or a systolic pressure drop
  • by at least 40 mmHg for at least 15 minutes), not caused by new\-onset
  • arrhythmia, hypovolemia, or sepsis
  • \* Patients who presented with temporary need for fluid resuscitation and/or

Outcomes

Primary Outcomes

Not specified

Similar Trials